These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30102844)

  • 1. Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients.
    Burghuber CK; Manook M; Ezekian B; Gibby AC; Leopardi FV; Song M; Jenks J; Saccoccio F; Permar S; Farris AB; Iwakoshi NN; Kwun J; Knechtle SJ
    Am J Transplant; 2019 Mar; 19(3):724-736. PubMed ID: 30102844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.
    Ezekian B; Schroder PM; Mulvihill MS; Barbas A; Collins B; Freischlag K; Yoon J; Yi JS; Smith F; Olaso D; Saccoccio FM; Permar S; Farris AB; Kwun J; Knechtle SJ
    J Am Soc Nephrol; 2019 Dec; 30(12):2399-2411. PubMed ID: 31658991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Belatacept-Resistant Rejection Is Associated With CD28
    Mathews DV; Wakwe WC; Kim SC; Lowe MC; Breeden C; Roberts ME; Farris AB; Strobert EA; Jenkins JB; Larsen CP; Ford ML; Townsend R; Adams AB
    Am J Transplant; 2017 Sep; 17(9):2285-2299. PubMed ID: 28502128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model.
    Samy KP; Anderson DJ; Lo DJ; Mulvihill MS; Song M; Farris AB; Parker BS; MacDonald AL; Lu C; Springer TA; Kachlany SC; Reimann KA; How T; Leopardi FV; Franke KS; Williams KD; Collins BH; Kirk AD
    Am J Transplant; 2017 May; 17(5):1193-1203. PubMed ID: 27888551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Belatacept-Based Maintenance Immunosuppression Controls the Post-Transplant Humoral Immune Response in Highly Sensitized Nonhuman Primates.
    Schmitz R; Fitch ZW; Manook M; Schroder PM; Choi AY; Olaso D; Yoon J; Bae Y; Shaw BI; Song M; Kuchibhatla M; Farris AB; Kirk A; Kwun J; Knechtle SJ
    Kidney360; 2022 Dec; 3(12):2116-2130. PubMed ID: 36591367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study.
    Mulvihill MS; Samy KP; Gao QA; Schmitz R; Davis RP; Ezekian B; Leopardi F; Song M; How T; Williams K; Barbas A; Collins B; Kirk AD
    Am J Transplant; 2019 Aug; 19(8):2350-2357. PubMed ID: 30891931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of Anti-CD40 Monoclonal Antibody to Nonmyeloablative Conditioning With Belatacept Abrogated Allograft Tolerance Despite Induction of Mixed Chimerism.
    Oura T; Hotta K; Rosales I; Dehnadi A; Kawai K; Lee H; Benedict Cosimi A; Kawai T
    Transplantation; 2019 Jan; 103(1):168-176. PubMed ID: 30113996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant.
    Manook M; Olaso D; Anwar IJ; Yoon J; Delaura I; Bae Y; Moris D; Shaw B; Song M; Farris AB; Jackson A; Kwun J; Knechtle S
    Sci Adv; 2023 May; 9(20):eadg1448. PubMed ID: 37205758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys.
    Song L; Ma A; Dun H; Hu Y; Fujii Y; Kinugasa F; Oshima S; Higashi Y; Daloze P; Chen H
    Am J Transplant; 2017 Mar; 17(3):635-645. PubMed ID: 27598231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of anti-CD40 antibody-mediated costimulation blockade on long-term survival of full-thickness porcine corneal grafts in nonhuman primates.
    Kim J; Choi SH; Lee HJ; Kim HP; Kang HJ; Kim JM; Hwang ES; Park CG; Kim MK
    Am J Transplant; 2018 Sep; 18(9):2330-2341. PubMed ID: 29722120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Pretransplant Frequency of CD28
    Cortes-Cerisuelo M; Laurie SJ; Mathews DV; Winterberg PD; Larsen CP; Adams AB; Ford ML
    Am J Transplant; 2017 Sep; 17(9):2350-2362. PubMed ID: 28502091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Evaluation of αCD40 (2C10R4) and αCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model.
    OʼNeill NA; Zhang T; Braileanu G; Sun W; Cheng X; Hershfeld A; Laird CT; Kronfli A; Hock LA; Dahi S; Kubicki N; Sievert E; Hassanein W; Cimeno A; Pierson RN; Azimzadeh AM
    Transplantation; 2017 Sep; 101(9):2038-2047. PubMed ID: 28557955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection.
    Kim EJ; Kwun J; Gibby AC; Hong JJ; Farris AB; Iwakoshi NN; Villinger F; Kirk AD; Knechtle SJ
    Am J Transplant; 2014 Jan; 14(1):59-69. PubMed ID: 24354871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function.
    Adams AB; Goldstein J; Garrett C; Zhang R; Patzer RE; Newell KA; Turgeon NA; Chami AS; Guasch A; Kirk AD; Pastan SO; Pearson TC; Larsen CP
    Am J Transplant; 2017 Nov; 17(11):2922-2936. PubMed ID: 28544101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Immunotherapy With Belatacept and BTLA Overexpression Attenuates Acute Rejection Following Kidney Transplantation.
    Zhang H; Wang Z; Zhang J; Gui Z; Han Z; Tao J; Chen H; Sun L; Fei S; Yang H; Tan R; Chandraker A; Gu M
    Front Immunol; 2021; 12():618737. PubMed ID: 33732243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative carfilzomib and lulizumab based desensitization prolongs graft survival in a sensitized non-human primate model.
    Schroder PM; Schmitz R; Fitch ZW; Ezekian B; Yoon J; Choi AY; Manook M; Barbas A; Leopardi F; Song M; Farris AB; Collins B; Kwun J; Knechtle SJ
    Kidney Int; 2021 Jan; 99(1):161-172. PubMed ID: 32898569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection.
    Kim SC; Wakwe W; Higginbotham LB; Mathews DV; Breeden CP; Stephenson AC; Jenkins J; Strobert E; Price K; Price L; Kuhn R; Wang H; Yamniuk A; Suchard S; Farris AB; Pearson TC; Larsen CP; Ford ML; Suri A; Nadler S; Adams AB
    Am J Transplant; 2017 May; 17(5):1182-1192. PubMed ID: 28097811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-7 receptor heterogeneity as a mechanism for repertoire change during postdepletional homeostatic proliferation and its relation to costimulation blockade-resistant rejection.
    Xu H; Bendersky VA; Brennan TV; Espinosa JR; Kirk AD
    Am J Transplant; 2018 Mar; 18(3):720-730. PubMed ID: 29136317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
    Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW; Strobert E; Hennigar R; Larsen CP
    Transplantation; 2002 Oct; 74(7):933-40. PubMed ID: 12394833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.
    Xu H; Samy KP; Guasch A; Mead SI; Ghali A; Mehta A; Stempora L; Kirk AD
    Am J Transplant; 2016 Feb; 16(2):550-64. PubMed ID: 26436448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.